| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $20.9M | +20.2% |
| SG&A Expense | $26.4M | +43.5% |
| Operating Income | -$47.4M | -66.7% |
| Interest Expense | $1.4M | -52.4% |
| Pre-tax Income | -$43.3M | -44.2% |
| Income Tax | $0 | +100.0% |
| Net Income | -$43.3M | -46.8% |
| EPS (Basic) | -$0.06 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.8M | +21.6% |
| Current Assets | $74.8M | +17.3% |
| Total Assets | $76.4M | +14.9% |
| Current Liabilities | $13.8M | +46.0% |
| Total Liabilities | $15.4M | -3.4% |
| Stockholders' Equity | $61.0M | +20.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.8M | -55.4% |
| Investing Cash Flow | -$699K | -66.8% |
| Financing Cash Flow | $46.1M | +478.8% |
| -50.0% |
| EPS (Diluted) | -$0.06 | -50.0% |